World's largest Real-World CGM study aims to unlock diabetes management secrets
NCT ID NCT07681024
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This global registry study follows 5,000 people with diabetes who use a Dexcom continuous glucose monitor (CGM). Researchers will track changes in HbA1c, a key measure of blood sugar control, over time. The goal is to understand how CGM use affects diabetes management in real-world settings across different countries and diabetes types.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Dexcom continuous glucose monitor (CGM)
What this could lead to
If successful, this study could provide real-world evidence on how CGM use improves blood sugar control over time for different types of diabetes.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may vary by country and individual use patterns.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Chelation Therapy for Critical Limb Ischemia Tri NCT03982693
- Polypill Trial for Heart Risk in China (NCT07679828)
- Diabetes Support Trial: FindHelp & Peer Support NCT07676188
- Wearable Insoles for Diabetic Ulcer Prevention (NCT07674420)
- ReCET for Type 2 Diabetes Trial (NCT06267391)
- PPG Upstroke Time vs Toe Pressure in Diabetic PA NCT05795582
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••